Al Aqar Valuation
| 5116 Stock | 1.37 0.02 1.44% |
Today, the firm appears to be fairly valued. Al Aqar Healthcare owns a latest Real Value of USD1.35 per share. The recent price of the firm is USD1.37. Our model approximates the value of Al Aqar Healthcare from examining the firm fundamentals such as EBITDA of 99.22 M, net income of 72.78 M, and Current Valuation of 1.52 B as well as evaluating its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Al Aqar's price fluctuation is moderately volatile at this time. Calculation of the real value of Al Aqar Healthcare is based on 3 months time horizon. Increasing Al Aqar's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the 5116 stock is determined by what a typical buyer is willing to pay for full or partial control of Al Aqar Healthcare. Since Al Aqar is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 5116 Stock. However, Al Aqar's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.37 | Real 1.35 | Hype 1.37 | Naive 1.37 |
The intrinsic value of Al Aqar's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Al Aqar's stock price.
Estimating the potential upside or downside of Al Aqar Healthcare helps investors to forecast how 5116 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Al Aqar more accurately as focusing exclusively on Al Aqar's fundamentals will not take into account other important factors: Al Aqar Total Value Analysis
Al Aqar Healthcare is presently estimated to have takeover price of 1.52 B with market capitalization of 897.9 M, debt of 683.88 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Al Aqar fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.52 B | 897.9 M | 683.88 M |
Al Aqar Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of 5116 suggests not a very effective usage of assets in November.Al Aqar Profitability Analysis
The company reported the revenue of 114.07 M. Net Income was 72.78 M with profit before overhead, payroll, taxes, and interest of 0.About Al Aqar Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Al Aqar Healthcare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Al Aqar Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Al Aqar's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Al Aqar's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Al Aqar. We calculate exposure to Al Aqar's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Al Aqar's related companies.8 Steps to conduct Al Aqar's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Al Aqar's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Al Aqar's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Al Aqar's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Al Aqar's revenue streams: Identify Al Aqar's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Al Aqar's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Al Aqar's growth potential: Evaluate Al Aqar's management, business model, and growth potential.
- Determine Al Aqar's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Al Aqar's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in 5116 Stock
Al Aqar financial ratios help investors to determine whether 5116 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 5116 with respect to the benefits of owning Al Aqar security.